Cerevel Therapeutics (CERE)
(Real Time Quote from BATS)
$40.34 USD
+0.03 (0.07%)
Updated Jul 15, 2024 09:40 AM ET
2-Buy of 5 2
C Value F Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | -0.58 |
EPS Last Quarter | -0.73 |
Last EPS Surprise | -19.67% |
ABR | 2.80 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.59 |
Next Year | -2.84 |
EPS (TTM) | -2.73 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.58 | -0.61 | -2.59 | -2.84 |
# of Estimates | 5 | 5 | 9 | 7 |
Most Recent Consensus | -0.57 | -0.64 | -2.73 | -3.20 |
High Estimate | -0.43 | -0.42 | -1.76 | -2.54 |
Low Estimate | -0.71 | -0.72 | -3.19 | -3.20 |
Year ago EPS | -0.63 | -0.61 | -2.67 | -2.59 |
Year over Year Growth Est. | 7.94% | 0.00% | 3.00% | -9.99% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.58 | -0.61 | -2.59 | -2.84 |
7 Days Ago | -0.58 | -0.61 | -2.59 | -2.84 |
30 Days Ago | -0.59 | -0.62 | -2.59 | -2.84 |
60 Days Ago | -0.62 | -0.66 | -2.68 | -2.92 |
90 Days Ago | -0.62 | -0.66 | -2.68 | -2.90 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.58 | -0.61 | -2.59 | -2.84 |
Zacks Consensus Estimate | -0.58 | -0.61 | -2.59 | -2.84 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.73 | -0.76 | -0.61 | -0.63 | NA |
Estimate | -0.61 | NA | -0.63 | -0.65 | NA |
Difference | -0.12 | NA | 0.02 | 0.02 | -0.03 |
Surprise | -19.67% | NA | 3.17% | 3.08% | -4.47% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more